Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Catalent is set to launch its new OneBio Suite for the integrated development, manufacturing, and clinical supply of biologic drugs.
read more
Cantargia and Patheon Biologics have signed an agreement regarding future production of the antibody CAN04 (nidanilimab).
read more
STA Pharmaceutical, a subsidiary of WuXi AppTec, and Dizal Pharmaceutical have announced a strategic partnership.
read more
Sekisui Diagnostics Enzyme business announces the completion of a new BioProcess Innovation Centre at the site in Maidstone, Kent by the end of 2019, following a $1.9 million investment.
read more
Thermo Fisher Scientific has entered into a definitive agreement to acquire a drug substance manufacturing site in Cork, Ireland, from GlaxoSmithKline.
read more
Aphena Pharma Solutions is investing in a $7 million company-wide expansion for future growth opportunities to be completed by the end of 2019.
read more
SmartCelle is Altus Formulation's proprietary polymeric micellar technology for parenteral, oral and topical delivery of insoluble molecules.
read more
Advarra has been selected by the I-ACT for Children to provide central institutional review board services to the organization’s pediatric clinical trial site network.
read more
SEKISUI XenoTech will celebrate its 25th anniversary this November, coming into the year with record-breaking achievements.
read more
Zenith Technologies has reported 400 per cent growth in its Chinese operations in the last 3 years.
read more
Pharmaceutical and biopharmaceutical companies that outsource manufacturing see their relationship with manufacturers differently than do CDMOs and CMOs.
read more
Catalent has completed the $1.2 billion acquisition of Paragon Bioservices, a viral vector development and manufacturing partner for gene therapies.
read more
DelMar Pharmaceuticals has announced the appointments of three additional neuro-oncologists to its Scientific Advisory Board (SAB).
read more
MilliporeSigma announced its participation in a collaboration with the Vaccine Formulation Institute and the European Vaccine Initiative.
read more
CalAmp has announced a collaboration with Cryoport to develop a next generation condition monitoring system to further assure the security of global temperature controlled pharmaceutical shipments.
read more